guselkumab,risankizumab
janssen,abbvie,boehringer ingelheim
['thanks', 'guselkumab', ' psa', 'risan', '#psa']
#eular2023 recommendation update summary from the 2018 in #psa whats new! - 3 more drugs now available in psa. guselkumab, upadacitnib, risankizumab (1 more in the pipeline)
- safety now to to considered!
- consider the full picture - extraarticular manifestations 
Rheumatologist @HSpecialSurgery @WeillCornell ClinicalResearch | Big Data | Outcomes | Epidemiology | Disparities | Table tennis player | Tweets are my own.